What happened
GeneOne Life Science updated the terms of convertible bonds to raise US$7M, about 20.6% of its market value.
For context, this raise equals about 20.6% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$7M |
| vs. market value | 20.6% |
| Filed | 2026-01-30, [Amended] Material event report (convertible bonds) |
| Source | DART rcept 20260130000444 → open original filing |
Source: DART. Information only, not investment advice.